Search results
Mar 1, 2024 · Since October 2020, surveillance for RSV hospitalizations has occurred year-round excluding May–June 2022. Surveillance for COVID-19 hospitalizations has occurred year-round since March 2020. Cumulative rates for the 2023–2024 season are not presented as surveillance is ongoing .
- Overview
- Explore deeper data
•The amount of respiratory illness (fever plus cough or sore throat) causing people to seek healthcare is elevated across many areas of the country. This week, 27 jurisdictions experienced high or very high activity compared to 25 jurisdictions last week.
•Nationally, emergency department visits with diagnosed COVID-19, influenza, and RSV are decreasing.
•Influenza test positivity remained stable nationally but is increasing in the Northeastern, Mid-Atlantic, Midwest, and Central parts of the country. COVID-19 and RSV test positivity decreased compared to the previous week.
•Nationally, COVID-19 wastewater viral activity levels, which reflect both symptomatic and asymptomatic infections, remain at high levels, particularly in the South, but are trending downward.
Reported on Friday, February 16th, 2024.
Level of Respiratory Illness Activity
State Map of Outpatient Respiratory Illness Activity
Outpatient Illness and Viral Surveillance
State Map of Emergency Department Use for COVID-19
COVID-19 Testing, Hospitalization, and Death Trends
Weekly U.S. Influenza Surveillance Report
RSV Testing Trends in the U.S.
People also ask
Will there be additional respiratory disease outlooks in 2023-2024?
Is the National per capita hospitalization rate declining in 2023-2024?
What is the peak hospitalization rate compared to 2022-2023?
Feb 8, 2024 · Outlook. CDC expects the upcoming fall and winter respiratory disease season will likely have a similar number of total hospitalizations compared to last year. As with last year, the number of hospitalizations is expected to be higher than that experienced prior to the COVID-19 pandemic, when severe disease was caused primarily by the influenza ...
Apr 4, 2023 · Using the 3% epidemic threshold, no seasonal RSV epidemic was observed to occur during the 2020–21 surveillance year (Figure 1). The number of tests performed increased substantially during the pandemic (Table).
- 10.15585/mmwr.mm7214a1
- 2023/04/04
Mar 11, 2021 · are updated each year and are available online here. ACIP recommendations often indicate a range of recommended ages for a specific dose in a series to be administered (e.g., between 12 and 15 months old). According to ACIP recommendations, if a case has received the appropriate number of doses for their age and
The Centers for Disease Control and Prevention (CDC) is issuing this Health Alert Network (HAN) Health Advisory about early, elevated respiratory disease incidence caused by multiple viruses occurring especially among children and placing strain on healthcare systems. Co-circulation of respiratory syncytial virus (RSV), influenza viruses, SARS ...
Sep 14, 2023 · Analysis from CDC’s Center for Forecasting and Outbreak Analytics shows that with the addition of a third virus (COVID-19) that can cause severe disease, even an average respiratory season can place significant strain on our healthcare system.
